Literature DB >> 22570300

Peptoid-Peptide hybrid ligands targeting the polo box domain of polo-like kinase 1.

Fa Liu1, Jung-Eun Park, Wen-Jian Qian, Dan Lim, Andrej Scharow, Thorsten Berg, Michael B Yaffe, Kyung S Lee, Terrence R Burke.   

Abstract

We replaced the amino terminal Pro residue of the Plk1 polo-box-domain-binding pentapeptide (PLHSpT) with a library of N-alkyl-Gly "peptoids", and identified long-chain tethered phenyl moieties giving greater than two-orders-of-magnitude affinity enhancement. Further simplification by replacing the peptoid residue with appropriate amides gave low-nanomolar affinity N-acylated tetrapeptides. Binding of the N-terminal long-chain phenyl extension was demonstrated by X-ray co-crystal data.
Copyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22570300      PMCID: PMC4536914          DOI: 10.1002/cbic.201200206

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


  26 in total

1.  Design and pharmacology of peptoids and peptide-peptoid hybrids based on the melanocortin agonists core tetrapeptide sequence.

Authors:  Jerry Ryan Holder; Rayna M Bauzo; Zhimin Xiang; Joseph Scott; Carrie Haskell-Luevano
Journal:  Bioorg Med Chem Lett       Date:  2003-12-15       Impact factor: 2.823

2.  Hydrazone- and hydrazide-containing N-substituted glycines as peptoid surrogates for expedited library synthesis: application to the preparation of Tsg101-directed HIV-1 budding antagonists.

Authors:  Fa Liu; Andrew G Stephen; Catherine S Adamson; Karine Gousset; M Javad Aman; Eric O Freed; Robert J Fisher; Terrence R Burke
Journal:  Org Lett       Date:  2006-10-26       Impact factor: 6.005

Review 3.  The medicinal chemistry of peptides.

Authors:  J J Nestor
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

4.  Improving SH3 domain ligand selectivity using a non-natural scaffold.

Authors:  J T Nguyen; M Porter; M Amoui; W T Miller; R N Zuckermann; W A Lim
Journal:  Chem Biol       Date:  2000-07

5.  Identification of high affinity polo-like kinase 1 (Plk1) polo-box domain binding peptides using oxime-based diversification.

Authors:  Fa Liu; Jung-Eun Park; Wen-Jian Qian; Dan Lim; Andrej Scharow; Thorsten Berg; Michael B Yaffe; Kyung S Lee; Terrence R Burke
Journal:  ACS Chem Biol       Date:  2012-02-14       Impact factor: 5.100

Review 6.  Peptoid-Peptide hybrid backbone architectures.

Authors:  Christian A Olsen
Journal:  Chembiochem       Date:  2010-01-25       Impact factor: 3.164

7.  Structural and functional analyses of minimal phosphopeptides targeting the polo-box domain of polo-like kinase 1.

Authors:  Sang-Moon Yun; Tinoush Moulaei; Dan Lim; Jeong K Bang; Jung-Eun Park; Shilpa R Shenoy; Fa Liu; Young H Kang; Chenzhong Liao; Nak-Kyun Soung; Sunhee Lee; Do-Young Yoon; Yoongho Lim; Dong-Hee Lee; Akira Otaka; Ettore Appella; James B McMahon; Marc C Nicklaus; Terrence R Burke; Michael B Yaffe; Alexander Wlodawer; Kyung S Lee
Journal:  Nat Struct Mol Biol       Date:  2009-07-13       Impact factor: 15.369

8.  Exploiting the basis of proline recognition by SH3 and WW domains: design of N-substituted inhibitors.

Authors:  J T Nguyen; C W Turck; F E Cohen; R N Zuckermann; W A Lim
Journal:  Science       Date:  1998-12-11       Impact factor: 47.728

9.  Inhibition of polo-like kinase 1 by blocking polo-box domain-dependent protein-protein interactions.

Authors:  Wolfgang Reindl; Juping Yuan; Andrea Krämer; Klaus Strebhardt; Thorsten Berg
Journal:  Chem Biol       Date:  2008-05

Review 10.  The growing applications of click chemistry.

Authors:  John E Moses; Adam D Moorhouse
Journal:  Chem Soc Rev       Date:  2007-05-03       Impact factor: 54.564

View more
  18 in total

Review 1.  Recent Advances and New Strategies in Targeting Plk1 for Anticancer Therapy.

Authors:  Kyung S Lee; Terrence R Burke; Jung-Eun Park; Jeong K Bang; Eunhye Lee
Journal:  Trends Pharmacol Sci       Date:  2015-10-17       Impact factor: 14.819

2.  Design and synthesis of a reagent for solid-phase incorporation of the phosphothreonine mimetic (2S,3R)-2-amino-3-methyl-4-phosphonobutyric acid (Pmab) into peptides in a bio-reversible phosphonyl-bis-pivaloyloxymethyl (POM) prodrug form.

Authors:  Wen-Jian Qian; Terrence R Burke
Journal:  Amino Acids       Date:  2013-08-02       Impact factor: 3.520

3.  Peptide-based inhibitors of Plk1 polo-box domain containing mono-anionic phosphothreonine esters and their pivaloyloxymethyl prodrugs.

Authors:  Wen-Jian Qian; Jung-Eun Park; Dan Lim; Suk-Youl Park; Ki-Won Lee; Michael B Yaffe; Kyung S Lee; Terrence R Burke
Journal:  Chem Biol       Date:  2013-10-10

4.  Enhancing polo-like kinase 1 selectivity of polo-box domain-binding peptides.

Authors:  Xue Zhi Zhao; David Hymel; Terrence R Burke
Journal:  Bioorg Med Chem       Date:  2017-02-28       Impact factor: 3.641

5.  Histidine N(τ)-cyclized macrocycles as a new genre of polo-like kinase 1 polo-box domain-binding inhibitors.

Authors:  David Hymel; Robert A Grant; Kohei Tsuji; Michael B Yaffe; Terrence R Burke
Journal:  Bioorg Med Chem Lett       Date:  2018-08-19       Impact factor: 2.823

6.  Development of cyclic peptomer inhibitors targeting the polo-box domain of polo-like kinase 1.

Authors:  Ravichandran N Murugan; Jung-Eun Park; Dan Lim; Mija Ahn; Chaejoon Cheong; Taeho Kwon; Ky-Youb Nam; Sun Ho Choi; Bo Yeon Kim; Do-Young Yoon; Michael B Yaffe; Dae-Yeul Yu; Kyung S Lee; Jeong Kyu Bang
Journal:  Bioorg Med Chem       Date:  2013-02-27       Impact factor: 3.641

7.  Application of oxime-diversification to optimize ligand interactions within a cryptic pocket of the polo-like kinase 1 polo-box domain.

Authors:  Xue Zhi Zhao; David Hymel; Terrence R Burke
Journal:  Bioorg Med Chem Lett       Date:  2016-09-02       Impact factor: 2.823

8.  Non-proteinogenic amino acids in the pThr-2 position of a pentamer peptide that confer high binding affinity for the polo box domain (PBD) of polo-like kinase 1 (Plk1).

Authors:  Wen-Jian Qian; Jung-Eun Park; Kyung S Lee; Terrence R Burke
Journal:  Bioorg Med Chem Lett       Date:  2012-10-27       Impact factor: 2.823

9.  Mono-anionic phosphopeptides produced by unexpected histidine alkylation exhibit high Plk1 polo-box domain-binding affinities and enhanced antiproliferative effects in HeLa cells.

Authors:  Wen-Jian Qian; Jung-Eun Park; Dan Lim; Christopher C Lai; James A Kelley; Suk-Youl Park; Ki Won Lee; Michael B Yaffe; Kyung S Lee; Terrence R Burke
Journal:  Biopolymers       Date:  2014-11       Impact factor: 2.505

10.  Using ligand-mapping simulations to design a ligand selectively targeting a cryptic surface pocket of polo-like kinase 1.

Authors:  Yaw Sing Tan; Paweł Śledź; Steffen Lang; Christopher J Stubbs; David R Spring; Chris Abell; Robert B Best
Journal:  Angew Chem Int Ed Engl       Date:  2012-09-07       Impact factor: 15.336

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.